Program
Monday, 8 June 2009
14:00 - 15:00 Oral session - Lung Cancer (Session Code: O1_P2)
-
Chairperson(s):
Joost NUYTTENS(Rotterdam, The Netherlands)
Weon-Kuu CHUNG(DAEJEON, Republic of Korea)
14:00
O1_P2 01 CHARLSON CO-MORBIDITY INDEX PREDICTS FOR MORTALITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR MEDICALLY INOPERABLE EARLY STAGE NON-SMALL CELL LUNG CANCER
Neil Kopek(Aarhus,Denmark)
14:10
O1_P2 02 PERIPHERAL EARLY STAGE LUNG TUMORS TREATED WITH REAL-TIME TUMOR TRACKING DURING STEREOTACTIC RADIOTHERAPY: A 3 YEARS EXPERIENCE
Joost Nuyttens(Rotterdam,The Netherlands)
14:20
O1_P2 03 STEREOTACTIC PROTON RADIOTHERAPY MAY OFFER REDUCED NORMAL LUNG EXPOSURE FOR PATIENTS WITH LOCALIZED NON-SMALL CELL LUNG CANCER WHO ARE CANDIDATES FOR PHOTON BASED STEREOTACTIC RADIOTHERAPY
Soon Huh(Jacksonville,United States)
14:30
O1_P2 04 FOUR-DIMENSIONAL LUNG TUMOR TRACKING FOR CENTRAL TUMORS DURING STEREOTACTIC RADIOTHERAPY
Joost Nuyttens(Rotterdam,The Netherlands)
14:40
O1_P2 05 THE CLINICAL EFFECT ANALYSIS OF BODY ROTATING GAMMA SYSTEM RADIOSURGERY FOR LUNG CANCER WITH SUPERIOR VENA CAVA SYNDROME
Feng Shouxin(Xuzhou,China)
14:50
O1_P2 06 SHORT-TERM THERAPEUTIC EFFECTIVENESS OF BODY ROTATING GAMMA SYSTEM WITH CONCURRENT CHEMOTHERAPY IN PATIENTS WITH ADVANCED NSCLC
Haiying Cao(Shenzhen,China)
